MG
EQ icon

Michael Gelband’s Equillium EQ Stock Holding History

Michael Gelband’s Portfolio EQ Stock Details EQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$141K Buy
+44,189
New +$106K ﹤0.01% 1450
2021
Q2 		– Sell
-14,000
Closed -$100K – 2475
2021
Q1 		$100K Buy
+14,000
New +$100K ﹤0.01% 1981

Other funds holding EQ

JT
Jupiter Topco New York $245B AUM
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Michael Gelband's EQ Position: Q2 2026 in Review

Michael Gelband opened a new position in Equillium (EQ) in Q2 2026: 44,189 shares worth $141K. The stake represents ﹤0.01% of the portfolio and ranks #1450 among its holdings. This is a return to the name: Michael Gelband previously reported a position in EQ as recently as Q1 2021.

Michael Gelband first reported a position in EQ in Q1 2021 and has held it in 2 quarters since. 60 funds tracked by Wall St. Rank hold EQ as of Q2 2026.

  • Michael Gelband held 44,189 shares of Equillium worth $141K as of Q2 2026.
  • Equillium was a new Michael Gelband position in Q2 2026.
  • Equillium made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1450 holding.
  • Michael Gelband first reported a position in Equillium in Q1 2021 and has held it in 2 quarters since.
  • 60 funds tracked by Wall St. Rank held Equillium as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.